ArticleJournal of thoracic disease2025
Construction and validation of a nomogram for predicting chronic obstructive pulmonary disease with bronchiectasis.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic obstructive pulmonary disease (COPD) coexisting with bronchiectasis (BE) leads to increased symptom severity, elevated mortality rates, and worsened clinical outcomes. This study aimed to determine the independent risk factors (RFs) associated with COPD combined with BE (COPD-BE), subsequently establishing and validating a nomogram-based clinical prediction model. This model aims to early identify the presence of BE in patients with COPD, so that clinicians can quickly identify COPD-BE patients and formulate targeted management strategies to improve their prognosis and reduce mortality. Methods: A total of 382 COPD patients were retrospectively enrolled and analyzed. Participants were randomly allocated at a 7:3 proportion into a training group comprising 268 cases and a validation group containing 114 cases. Subsequently, individuals were categorized based on whether BE was present, forming COPD-BE and COPD-alone subgroups. To identify RFs independently associated with COPD-BE, initial univariate logistic regression was performed, followed by least absolute shrinkage and selection operator (LASSO) regression for variable selection, and ultimately multivariable regression modeling. Using factors determined by the multivariate analysis, a predictive nomogram was subsequently developed. Receiver operating characteristic (ROC) analyses were conducted, and corresponding areas under the curve (AUCs) were calculated, to evaluate the predictive accuracy of the model. The nomogram's clinical effectiveness and accuracy were further validated through calibration assessments and decision curve analysis (DCA). Results: Independent RFs for COPD-BE included female sex, hemoptysis, history of pulmonary tuberculosis, Conclusions: Female sex, hemoptysis, pulmonary tuberculosis history, Pseudomonas aeruginosa infection, globulin level, and mechanical ventilation duration are independent RFs for COPD-BE. The predictive model developed based on these factors demonstrated good predictive performance in internal validation. Pending further external validation, this nomogram holds promise as a useful tool to aid in the early identification of COPD-BE in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.